Biogen News, Biogen Quote, BIIB Quote

Biogen (NQ:BIIB) Delayed: 200.26 +0.55 (0.28%)

Prev. Close

$199.71

Today 6M 1Y 5Y

Open

$198.88

52 Wk High

$333.65

52 Wk Low

$223.02

Day High

$201.00

Day Low

$198.42

P/E

25.64

EPS

$7.81

Volume

287,847

Friends, Peers and Foes (?): STOK, IONS, ALNY, APLS, REGN (more...)

ALERTS | RSS

Jun 22, 2026 09:05 AM International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma
Jun 22, 2026 08:30 AM Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
Jun 22, 2026 07:33 AM Biogen (BIIB) Reiterated at Overweight by Cantor Fitzgerald: Advancing with BIIB080
Jun 18, 2026 07:06 AM Needham Reiterates Buy Rating on Biogen (BIIB)
Jun 17, 2026 06:59 PM Biogen to acquire RayThera for up to $1 billion
Jun 17, 2026 06:59 PM Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
Jun 15, 2026 06:38 AM Biogen (BIIB) PT Lowered to $221 at Mizuho
Jun 11, 2026 05:51 PM Form 4 BIOGEN INC. For: Jun 09 Filed by: HAWKINS WILLIAM A
Jun 11, 2026 05:48 PM Form 4 BIOGEN INC. For: Jun 09 Filed by: SHERWIN STEPHEN A
Jun 11, 2026 05:46 PM Form 4 BIOGEN INC. For: Jun 09 Filed by: Rowinsky Eric K

Entities mentioned with BIIB

View All Entities